Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

JAMA Oncology Author Interviews
30/01/2025 11 min
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Listen "Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD. Related Content: Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy

More episodes of the podcast JAMA Oncology Author Interviews

Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality 30/10/2025
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer 18/09/2025
Proportional Sedation for Persistent Agitated Delirium in Palliative Care 31/07/2025
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance 29/05/2025
Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury 24/04/2025
Accelerated Aging in Survivors of Childhood Cancer 20/03/2025
Academic-Community Partnership and Deaths in Promyelocytic Leukemia 27/02/2025
Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020 05/12/2024
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib 21/11/2024
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma 24/10/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA